UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 330

Sortiert nach

Management of atrial fibrillation in patients with hypertension

Journal of human hypertension, 1997-11, Vol.11 (11), p.699-707

1997

Volltextzugriff (PDF)

Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias

The American heart journal, 2000-04, Vol.139 (4), p.690-695

2000

Volltextzugriff (PDF)

P3797Increased risk of cardiovascular events and stroke among patients with atrial fibrillation and obstructive sleep apnea

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

P1034Impact of ablation status on the efficacy and safety of dronedarone in patients with atrial fibrillation/flutter: a post-hoc analysis of the ATHENA trial

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

P1903Efficacy and safety of dronedarone after recent cardioversion in patients with atrial fibrillation/flutter: a post-hoc analysis of the EURIDIS/ADONIS trials

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

Bioavailability of amiodarone tablets administered with and without food in healthy subjects

The American journal of cardiology, 2001-02, Vol.87 (4), p.432-435

2001

Volltextzugriff (PDF)

INVEST substudies: Design and patient characteristics

Clinical cardiology (Mahwah, N.J.), 2001-10, Vol.24 (S5), p.V-9-V-11

2001

Volltextzugriff (PDF)

Management and prevention of atrial fibrillation after cardiovascular surgery

The American journal of cardiology, 2000-05, Vol.85 (10), p.20-24

2000

Volltextzugriff (PDF)

Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study

The American heart journal, 2022-03, Vol.245, p.51-59

2022

Volltextzugriff (PDF)

Drug-induced long-QT syndrome and torsade de pointes: an underrated problem?

Europace (London, England), 2014-01, Vol.16 (1), p.4-5

2014

Volltextzugriff (PDF)

Clinical Outcome of Patients Who Develop PAF After CABG Surgery

Pacing and clinical electrophysiology, 2001-02, Vol.24 (2), p.191-193

2001

Volltextzugriff (PDF)

New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice

Archives of internal medicine (1960), 2000-09, Vol.160 (16), p.2429

2000

Volltextzugriff (PDF)

The burden of proof: The current state of atrial fibrillation prevention and treatment trials

Heart rhythm, 2017-05, Vol.14 (5), p.763-782

2017

Volltextzugriff (PDF)

Ventricular transmural repolarization sequence: its relationship with ventricular relaxation and role in ventricular diastolic function

European heart journal, 2009-02, Vol.30 (3), p.372-380

2009

Volltextzugriff (PDF)

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: Cardiac Safety Of Tiotropium In Patients With Cardiac Events: A Retrospective, Combined Analysis Of The Uplift® And Tiospir(TM) Trials

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

Pharmacological effects of antiarrhythmic drugs. Review and update

Archives of internal medicine (1960), 1998-02, Vol.158 (4), p.325

Kowey, P R

1998

Volltextzugriff (PDF)

Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia

Clinical cardiology (Mahwah, N.J.), 2000-03, Vol.23 (3), p.171-174

2000

Volltextzugriff (PDF)

Classification and pharmacology of antiarrhythmic drugs

The American heart journal, 2000-07, Vol.140 (1), p.12-20

2000

Volltextzugriff (PDF)

Ranolazine and Dronedarone in Combination Show Synergistic Effects on AF Suppression

MD conference express, 2014-07, Vol.14 (9), p.23-24

2014

Volltextzugriff (PDF)

Effect of an intravenous angiotensin-converting enzyme inhibitor on the electrophysiologic features of normal and hypertrophied feline ventricles

The American heart journal, 1996-11, Vol.132 (5), p.989-994

1996

Volltextzugriff (PDF)

Ventricular repolarization components on the electrocardiogram: Cellular basis and clinical significance

Journal of the American College of Cardiology, 2003-08, Vol.42 (3), p.401-409

2003

Volltextzugriff (PDF)

Safety and efficacy of amiodarone: the low-dose perspective

Chest, 1988, Vol.93 (1), p.54-59

1988

Volltextzugriff (PDF)

Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia

Circulation (New York, N.Y.), 2004-08, Vol.110 (9), p.1036-1041

2004

Volltextzugriff (PDF)

Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart

Circulation (New York, N.Y.), 1995-01, Vol.91 (2), p.426-430

1995

Volltextzugriff (PDF)

The Top Ten Fallacies of Nonsustained Ventricular Tachycardia

Pacing and clinical electrophysiology, 1997-11, Vol.20 (11), p.2825-2847

1997

Volltextzugriff (PDF)

26 – 50 von 330

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(314)
Mit Volltextzugriff
(292)

Publikationsform

Sprache

Englisch
(330)
Japanisch
(31)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(228)
Science & Technology
(228)
Cardiovascular System & Cardiology
(198)
Cardiac & Cardiovascular Systems
(196)
Humans
(195)
Male
(132)
Female
(127)
Aged
(98)
Biological And Medical Sciences
(89)
Medical Sciences
(88)
Middle Aged
(79)
Cardiac Arrhythmia
(58)
Aged, 80 And Over
(48)
Atrial Fibrillation - Drug Therapy
(48)
Atrial Fibrillation
(47)
Electrocardiography
(47)
Pharmacology. Drug Treatments
(47)
Anti-Arrhythmia Agents - Therapeutic Use
(46)
Cardiovascular System
(44)
Registries
(44)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Management of atrial fibrillation in patients with hypertension

Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias

P3797Increased risk of cardiovascular events and stroke among patients with atrial fibrillation and obstructive sleep apnea

P1034Impact of ablation status on the efficacy and safety of dronedarone in patients with atrial fibrillation/flutter: a post-hoc analysis of the ATHENA trial

P1903Efficacy and safety of dronedarone after recent cardioversion in patients with atrial fibrillation/flutter: a post-hoc analysis of the EURIDIS/ADONIS trials

Bioavailability of amiodarone tablets administered with and without food in healthy subjects

INVEST substudies: Design and patient characteristics

Management and prevention of atrial fibrillation after cardiovascular surgery

Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study

Drug-induced long-QT syndrome and torsade de pointes: an underrated problem?

Clinical Outcome of Patients Who Develop PAF After CABG Surgery

New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice

The burden of proof: The current state of atrial fibrillation prevention and treatment trials

Ventricular transmural repolarization sequence: its relationship with ventricular relaxation and role in ventricular diastolic function

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: Cardiac Safety Of Tiotropium In Patients With Cardiac Events: A Retrospective, Combined Analysis Of The Uplift® And Tiospir(TM) Trials

Pharmacological effects of antiarrhythmic drugs. Review and update

Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia

Classification and pharmacology of antiarrhythmic drugs

Ranolazine and Dronedarone in Combination Show Synergistic Effects on AF Suppression

Effect of an intravenous angiotensin-converting enzyme inhibitor on the electrophysiologic features of normal and hypertrophied feline ventricles

Ventricular repolarization components on the electrocardiogram: Cellular basis and clinical significance

Safety and efficacy of amiodarone: the low-dose perspective

Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia

Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart

The Top Ten Fallacies of Nonsustained Ventricular Tachycardia

Suchergebnisse filtern